BeOne Medicines (ONC) EBT (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 73.69% |
| Dec 31, 2025 | 1.41% |
| Sep 30, 2025 | 47.83% |
| Jun 30, 2025 | 376.31% |
| Mar 31, 2025 | 124.49% |
| Dec 31, 2024 | 13.18% |
| Sep 30, 2024 | 7.19% |
| Jun 30, 2024 | 56.49% |
| Mar 31, 2024 | 30.60% |
| Dec 31, 2023 | -252.95% |
| Sep 30, 2023 | 162.41% |
| Jun 30, 2023 | -9.06% |
| Mar 31, 2023 | 21.82% |
| Dec 31, 2022 | 21.82% |
| Sep 30, 2022 | 1.14% |
| Jun 30, 2022 | -32.36% |
| Mar 31, 2022 | 30.49% |
| Dec 31, 2021 | -39.94% |
| Sep 30, 2021 | 9.88% |
| Jun 30, 2021 | -876.81% |
| Mar 31, 2021 | 112.84% |
| Dec 31, 2020 | -10.79% |
| Sep 30, 2020 | -28.79% |
| Jun 30, 2020 | 7.04% |
| Mar 31, 2020 | 4.46% |
| Dec 31, 2019 | -21.95% |
| Sep 30, 2019 | -272.06% |
| Jun 30, 2019 | 49.97% |
| Mar 31, 2019 | 39.13% |
| Dec 31, 2018 | -89.88% |
| Sep 30, 2018 | 10.01% |
| Jun 30, 2018 | -48.43% |
| Mar 31, 2018 | -15.01% |
| Dec 31, 2017 | -182.61% |
| Sep 30, 2017 | 288.86% |
| Jun 30, 2017 | -19.90% |
| Mar 31, 2017 | -33.27% |
| Dec 31, 2016 | -7.02% |
| Sep 30, 2016 | -47.43% |
| Jun 30, 2016 | -9.25% |
| Mar 31, 2016 | -189.26% |
| Dec 31, 2015 | 275.72% |
| Sep 30, 2015 | -148.17% |
| Jun 30, 2015 | 44.76% |